acetylsalicylic acid lysinate has been researched along with prasugrel hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardo, E; Fernández, C; Fernández-Ortiz, A; Macaya, C; Martín, A; Núñez-Gil, I; Ortega-Pozzi, MA; Tirado, G; Vilacosta, I; Vivas, D | 1 |
| Bernardo, E; Fernández-Ortiz, A; Gómez-Polo, JC; Jiménez, JJ; Martín-Asenjo, R; Moreno, G; Ortega-Pozzi, MA; Pérez-Villacastín, J; Vilacosta, I; Vivas, D | 1 |
2 trial(s) available for acetylsalicylic acid lysinate and prasugrel hydrochloride
| Article | Year |
|---|---|
Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial).
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aspirin; Blood Platelets; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Lysine; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Young Adult | 2015 |
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial.
Topics: Aspirin; Blood Platelets; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome | 2023 |